Trientine Hydrochloride
- Product NDC
- 66435-700
- 11-digit product format
- 664350700
- Labeler code
- 66435
- Product ID
- 66435-700_463a763f-bba2-49e3-a8e8-1677c3aa121b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trientine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Kadmon Pharmaceuticals, LLC
- Application
- ANDA209415
- Marketing category
- ANDA
- Marketing start
- 2019-09-30
- Marketing end
- 2021-09-30
- Substance
- TRIENTINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Metal Chelating Activity [MoA],Metal Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66435-700-10 | 66435070010 | 100 CAPSULE in 1 BOTTLE (66435-700-10) | 100 capsule | 2019-09-30 | 2021-09-30 | No | No | Current |
| 66435-700-12 | 66435070012 | 12 CAPSULE in 1 BLISTER PACK (66435-700-12) | 12 capsule | 2019-10-21 | 2021-09-30 | No | No | Current |
| 66435-700-20 | 66435070020 | 10 CAPSULE in 1 CARTON (66435-700-20) | 10 capsule | 2019-10-21 | 2021-09-30 | No | No | Current |